🔗 Share this article

An underground economy for unapproved slimming drugs is being driven by social media fitness personalities and sellers on communication apps, according to new investigations.

Investigational Treatment Gaining Popularity Via Social Media

The experimental drug, which remains in clinical trials, is being advertised by online personalities for its alleged weight-reducing effects. Followers are encouraged to message these accounts directly for source information, while also receiving discount codes.

Thriving Trade on Social Networks

Additionally, a robust trade exists on messaging services, where communities with numerous of members share “before and after” images, injection guides and assertions of next-day UK delivery. Sellers market the drug there before redirecting buyers to other platforms for purchases.

Learning About The Experimental Drug

Retatrutide is an investigational injection created by American pharmaceutical company Eli Lilly. The treatment affects three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies suggest it could assist individuals reduce up to 25% of their body weight. Nicknamed the “triple G”, the drug is being hailed online as the successor to Ozempic.

Medical Professionals Voice Worries

Nevertheless, physicians and pharmacists have warned that the sale of what remains an unlicensed drug in the UK is a cause for concern and could lead to users administering substances of uncertain source.

Several professionals said the demand for the experimental drug could be connected to the increasing cost of approved weight loss products such as Mounjaro.

Legal Position and Implementation

Selling retatrutide on social media or Telegram is illegal in the UK, as it is an unlicensed drug that cannot be promoted or distributed for human use under the Human Medicines Regulations 2012.

Some influencers attempt to circumvent the rules by referring to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted substance, but advertising and distribution can still breach pharmaceutical, advertising, and consumer regulations, potentially leading to penalties, legal action or imprisonment.

Service Reaction and Content Elimination

According to TikTok, the service has taken down violative content and prohibited associated keywords and search suggestions. The company said it was committed to keeping the service secure and investing in strengthening compliance measures.

Online Trading Operations

Investigations also discovered communities with up to nine thousand participants marketing the experimental drug using Telegram's integrated search feature, which operates like a public directory. Typing “retatrutide” immediately brings up groups with numerous of members, populated with photos of slimming results, glowing testimonials and step-by-step instructions for preparing or administering at home.

Within minutes of entering one group, a seller posted WhatsApp details, where the majority of purchases take place. The seller provided an instruction manual and guaranteed shipping within two days. When asked whether the substance was authentic, one vendor said: “You can’t be sure.” Another provided a photo of a supposed testing documentation. Not one asked about body mass, medical conditions or previous experience.

Item Details and Pricing

Within these communities, messages display black plastic packages with postal service labels, claiming to contain fresh supplies. One communication read: “It took eight of us to load them this morning.”

Customers can select between powder vials, mixed at home with sterile water, or ready-to-use injectors typically sold at £160 for 20mg. When questioned how much time a injector should last, sellers give conflicting responses ranging from a several days to “depends on your body”.

Platform Moderation and Safety Actions

A spokesperson for Telegram said it regularly moderated dangerous material on its service including content that encouraged the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.

Healthcare Expert Warnings

“Individuals are administering substances they can’t verify. Even if the research behind retatrutide is valid, these online products may not include what they claim,” said Jason Murphy, the head of pharmacy at a pharmacy service.

Dr Crystal Wyllie of an online medical service linked the surge in interest to recent price rises for approved slimming medications such as Mounjaro. “With prices increasing, patients are using social media. But counterfeit treatments are highly risky. You can’t be certain what’s contained or whether the conditions they were produced in was clean,” she explained.

Her staff has previously seen individuals injured by self-injection from unconfirmed sources. “We recognize the frustration, but buying from messaging apps or WhatsApp is gambling with your well-being,” stated Wyllie. “These substances could be impure or incorrectly dosed.”

Manufacturer Position

A representative from the pharmaceutical company stated the substance was in phase 3 research studies and had not been reviewed or authorized by any regulatory agency globally. “Consequently at this time no one can sell [it] for personal consumption,” they explained, noting that any item “misleadingly claiming itself as a company investigational substance not yet authorized … may expose patients to possibly serious medical dangers”.